Regulatory Affairs 2018

8^th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR was held during June 08-09, 2018 at Doubletree by Hilton Hotel Philadelphia Airport, Philadelphia, USA. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Regulatory professionals, scientists, academicians representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Regulatory considerations in pharmaceutical & biopharmaceutical research and market” which included the following scientific tracks:  

Regulatory Affairs

Regulatory Affairs in Pharmacovigilance

Clinical Affairs and Regulatory Strategies

Regulatory Strategies and developments

Penalties for Regulatory Non-compliance

Biologics and Biosimilars

Global Regulatory Intelligence

Regulatory Communications and Submissions

Marketing Authorizations

Regulatory Requirements for Pharmaceuticals

Regulatory Challenges for Medical Devices

Medical Devices and Combination Product Regulations

Best Industry Practices

Intellectual Property Rights

GMP in Food Industry

Impact of Brexit on Regulatory Framework

Current GMP Guidelines (cGMP) & GxP in Pharmaceuticals:

Role of c in cGMP

Good Clinical Practices & Good Laboratory Practices

Softwares in GMP and GCP

Regulatory Affairs 2018 was moderated by Joel Finkle, (Acuta LLC, USA) & Raymond C Jagessar (University of Guyana, Guyana)

We are thankful to our below Honourable guests for their generous support and suggestions.

• Rashid Mahmood- Surge Laboratories, Pakistan
• R. Manavalan– RVS College of Pharmaceutical Sciences, India

The conference proceedings were carried out through various Scientific-sessions and plenary lectures of which the following topics were highlighted as Keynote-presentations:

• A personal history of regulatory submissions technology: Joel Finkle-ACUTA LLC, USA
• Various sessions were chaired and co-chaired by: Joel Finkle – Acuta LLC, USA.

Conference Series LLC Ltd has taken the privilege of felicitating Regulatory Affairs 2018 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Regulatory Affairs 2018. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Developing Drugs: Open Access as a special issue.